Reviewing IceCure Medical (NASDAQ:ICCM) & Tauriga Sciences (OTCMKTS:TAUG)

IceCure Medical (NASDAQ:ICCM) and Tauriga Sciences (OTCMKTS:TAUG) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, valuation and risk.

Analyst Recommendations

This is a breakdown of current ratings and price targets for IceCure Medical and Tauriga Sciences, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IceCure Medical	1	1	2	0	2.25
Tauriga Sciences	0	0	0	0	0.00

IceCure Medical currently has a consensus price target of $2.64, suggesting a potential upside of 269.67%. Given IceCure Medical’s stronger consensus rating and higher possible upside, research analysts plainly believe IceCure Medical is more favorable than Tauriga Sciences.

Profitability

This table compares IceCure Medical and Tauriga Sciences’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
IceCure Medical	-317.62%	-136.96%	-71.46%
Tauriga Sciences	N/A	N/A	N/A

Insider & Institutional Ownership

0.6% of IceCure Medical shares are held by institutional investors. 2.4% of IceCure Medical shares are held by insiders. Comparatively, 3.5% of Tauriga Sciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Earnings and Valuation

This table compares IceCure Medical and Tauriga Sciences”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IceCure Medical	$2.79 million	17.57	-$15.32 million	($0.16)	-4.46
Tauriga Sciences	N/A	N/A	N/A	N/A	N/A

Tauriga Sciences has lower revenue, but higher earnings than IceCure Medical.

Summary

IceCure Medical beats Tauriga Sciences on 5 of the 9 factors compared between the two stocks.

About IceCure Medical

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

About Tauriga Sciences

Tauriga Sciences, Inc. produces and sells cannabidiol infused chewing gum under the Tauri-Gum brand name. It also develops anti-nausea products; and skin care products include CBD facemasks; CBD daily moisturizer; CBD anti-wrinkle dream, hand, and foot cream with hemp seed oil; CBD massage and body oil; CBD body revive roll-on; CBD transdermal patch; and CBD body spray. In addition, the company offers rainbow deluxe sampler pack, CBD non-GMO dietary supplements, and CBD scented bath bombs. It sells its products through e-commerce, distributors, and wholesale channels. The company has a collaboration agreement with Aegea Biotechnologies, Inc. to develop a rapid, multiplexed COVID-19 (novel coronavirus) test. Tauriga Sciences, Inc. was founded in 2001 and is headquartered in Wappingers Falls, New York.